HCC & Cholangiocarcinoma Workshop (Overview)

Overview

This think tank meeting will focus on the two major cancers of the liver, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). The fully virtual meeting will be conducted April 7-8, 2025. The sessions have been designed to meet these key objectives:

  • Assess Disease Burden and Research Gaps:
    Review the current state of liver cancer and cholangiocarcinoma in terms of epidemiology, risk factors, and disease burden, highlighting ongoing research and identifying key challenges and opportunities.
  • Identify Research Gaps and Opportunities in Mechanistic, Clinical, and Population Research:
    Identify key gaps and opportunities in research in biological mechanisms, early detection, screening, prevention, and treatment strategies while addressing the clin
  • Engage Experts and Advocates for Future Research:
    Bring together a diverse group of experts and patient advocates to comprehensively explore the disease landscape, ensuring a collaborative approach to shape future research and public health strategies.
Planning committee:
Carmen Allegra (NCI)
Shaalan Beg (NCI)
MK Holohan (NCI)
Katherine McGlynn (NCI)
Steve Nothwehr (NCI)
Neeraja Sathyamoorthy (NCI)
Terese Trent (NCI)
Xin Wei Wang (NCI)
Melinda Bachini (CCA Foundation)
Sidney Fu (NCI)
Tram Kim Lam (NCI)
Karen Mowrer (NCI)
Betsy Read-Connole (NCI)
Asad Umar (NCI)
Andrea Wilson (Blue Faery: The Adrienne Wilson Liver Cancer Association)